Glutamate and addiction /

Saved in:
Bibliographic Details
Imprint:Totowa, N.J. : Humana Press, c2003.
Description:xviii, 440 p. : ill. ; 26 cm.
Language:English
Series:Contemporary clinical neuroscience
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4775655
Hidden Bibliographic Details
Other authors / contributors:Herman, Barbara H.
Frankenheim, Jerry.
ISBN:0896038793 (alk. paper)
Notes:Includes bibliographical references and index.
committed to retain 20170930 20421213 HathiTrust

MARC

LEADER 00000cam a22000004a 4500
001 4775655
003 ICU
005 20031111145100.0
008 020225s2003 njua b 001 0 eng
010 |a  2002190242 
020 |a 0896038793 (alk. paper) 
040 |a DNLM/DLC  |c DLC  |d DLC  |d OCoLC  |d OrLoB-B 
042 |a pcc 
050 0 0 |a RC564  |b .G585 2003 
060 1 0 |a WM 270  |b G567 2002 
082 0 0 |a 616.86  |2 21 
245 0 0 |a Glutamate and addiction /  |c edited by Barbara H. Herman ; coeditors, Jerry Frankenheim ... [et al.]. 
260 |a Totowa, N.J. :  |b Humana Press,  |c c2003. 
300 |a xviii, 440 p. :  |b ill. ;  |c 26 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Contemporary clinical neuroscience 
504 |a Includes bibliographical references and index. 
505 0 0 |g I.  |t Introduction: Physiology and Pharmacology of Glutamate /  |r Edited by Philip H. Sheridan, Forrest F. Weight and Barbara H. Herman --  |g 1.  |t Molecular Pharmacology and Physiology of Glutamate Receptors /  |r Karin Borges and Raymond Dingledine --  |g 2.  |t Pharmacology of Glutamate Receptors /  |r Jeffrey M. Witkin, Rafal Kaminski and Michael A. Rogawski --  |g 3.  |t Glutamate and Neurotoxicity /  |r B. Joy Snider and Dennis W. Choi --  |g 4.  |t Maturational Regulation of Glutamate Receptors and Their Role in Neuroplasticity /  |r Russell M. Sanchez and Frances E. Jensen --  |g 5.  |t Role of the NMDA Receptor in Neuronal Apoptosis and HIV-Associated Dementia /  |r Marcus Kaul and Stuart A. Lipton --  |g II.  |t Glutamate: Stimulant Drugs of Abuse (Cocaine, Amphetamine, Methamphetamine) /  |r Edited by Jerry Frankenheim and Barbara H. Herman --  |g 6.  |t Role of Glutamate and Nitric Oxide in the Acquisition and Expression of Cocaine-Induced Conditioned Increases in Locomotor Activity /  |r Agu Pert, Robert M. Post and Susan R. B. Weiss --  |g 7.  |t Interactions of Dopamine, Glutamate, and GABA Systems in Mediating Amphetamine- and Cocaine-Induced Stereotypy and Behavioral Sensitization /  |r Ralph Karler, David K. Thai and Larry D. Calder --  |g 8.  |t Addiction and Glutamate-Dependent Plasticity /  |r Marina E. Wolf --  |g 9.  |t Glutamate and Dopamine Interactions in the Motive Circuit: Implications for Craving /  |r David A. Baker, Jennifer L. Cornish and Peter W. Kalivas --  |g 10.  |t Glutamate Cascade from Metabotropic Glutamate Receptors to Gene Expression in Striatal Neurons: Implications for Psychostimulant Dependence and Medication /  |r John Q. Wang, Limin Mao and Yuen-Sum Lau --  |g 11.  |t Glutamate Neurotransmission in the Course of Cocaine Addiction /  |r Luigi Pulvirenti --  |g 12.  |t Glutamate and the Self-Administration of Psychomotor-Stimulant Drugs /  |r Paul Vezina and Nobuyoshi Suto --  |g 13.  |t Roles of Glutamate, Nitric Oxide, Oxidative Stress, and Apoptosis in the Neurotoxicity of Methamphetamine /  |r Jean Lud Cadet --  |g 14.  |t Methamphetamine Toxicity: Roles for Glutamate, Oxidative Processes, and Metabolic Stress /  |r Kristan B. Burrows and Bryan K. Yamamoto --  |g 15.  |t Nitric Oxide-Dependent Processes in the Action of Psychostimulants /  |r Yossef Itzhak, Julio L. Martin and Syed F. Ali --  |g 16.  |t Effects of Novel NMDA/Glycine-Site Antagonists on the Blockade of Cocaine-Induced Behavioral Toxicity in Mice /  |r Rae R. Matsumoto and Buddy Pouw --  |g 17.  |t Clinical Studies Using NMDA Receptor Antagonists in Cocaine and Opioid Dependence /  |r Adam Bisaga and Marian W. Fischman --  |g 18.  |t The Role of mGluR5 in the Effects of Cocaine: Implications for Medication Development /  |r Mark P. Epping-Jordan --  |g III.  |t Glutamate and Opiate Drugs (Heroin) of Abuse /  |r Edited by Barbara H. Herman and Jerry Frankenheim --  |g 19.  |t Role of the Glutamatergic System in Opioid Tolerance and Dependence: Effects of NMDA Receptor Antagonists /  |r Jianren Mao --  |g 20.  |t The Role of NMDA Receptors in Opiate Tolerance, Sensitization, and Physical Dependence: A Review of the Research, A Cellular Model, and Implications for the Treatment of Pain and Addiction /  |r Keith A. Trujillo --  |g 21.  |t Modification of Conditioned Reward by N-Methyl-D-aspartate Receptor Antagonists /  |r Piotr Popik --  |g 22.  |t Morphine Withdrawal as a State of Glutamate Hyperactivity: The Effects of Glutamate Receptor Subtype Ligands on Morphine Withdrawal Symptoms /  |r Kurt Rasmussen --  |g IV.  |t Glutamate and Alcohol Abuse and Alcoholism /  |r Edited by Forrest F. Weight and Raye Z. Litten --  |g 23.  |t Alcohol Actions on Glutamate Receptors /  |r Robert W. Peoples --  |g 24.  |t Glutamate and Alcohol-Induced Neurotoxicity /  |r Fulton T. Crews, Joseph G. Rudolph and L. Judson Chandler --  |g 25.  |t Role of Glutamate in Alcohol Withdrawal Kindling /  |r Howard C. Becker and Nicole Redmond --  |g 26.  |t Alcohol and Glutamate Neurotransmission in Humans: Implications for Reward, Dependence, and Treatment /  |r John H. Krystal, Ismene L. Petrakis, D. Cyril D'Souza, Graeme Mason and Louis Trevisan --  |g 27.  |t Mechanism of Action of Acamprosate Focusing on the Glutamatergic System /  |r W. Zieglgansberger, G. Rammes, R. Spanagel, W. Danysz and Ch. Parsons --  |g 28.  |t The NMDA/Nitric Oxide Synthase Cascade in Opioid Analgesia and Tolerance /  |r Gavril W. Pasternak and Yuri Kolesnikov --  |g 29.  |t Overview of Clinical Studies for Acamprosate /  |r Adriaan S. Potgieter. 
583 1 |a committed to retain  |c 20170930  |d 20421213  |f HathiTrust  |5 ICU 
650 0 |a Substance abuse  |x Pathophysiology. 
650 0 |a Glutamic acid  |x Physiological effect. 
650 1 2 |a Substance-Related Disorders  |x physiopathology. 
650 2 2 |a Glutamates  |x pharmacology. 
650 2 2 |a Receptors, Glutamate  |x physiology. 
650 7 |a Glutamic acid  |x Physiological effect.  |2 fast  |0 http://id.worldcat.org/fast/fst00943731 
650 7 |a Substance abuse  |x Pathophysiology.  |2 fast  |0 http://id.worldcat.org/fast/fst01136787 
700 1 |a Herman, Barbara H.  |0 http://id.loc.gov/authorities/names/n2002133351  |1 http://viaf.org/viaf/64237222 
700 1 |a Frankenheim, Jerry.  |0 http://id.loc.gov/authorities/names/n93002887  |1 http://viaf.org/viaf/45968264 
903 |a HeVa 
903 |a Hathi 
035 |a (OCoLC)49221947 
929 |a cat 
999 f f |i 32f49b87-960b-58f9-aca5-ac8e8fd23338  |s ed474833-2bfb-5d96-9b1f-d88023c464e5 
928 |t Library of Congress classification  |a RC564 .G585 2003  |l JCL  |c JCL-Sci  |i 4334008 
927 |t Library of Congress classification  |a RC564 .G585 2003  |l JCL  |c JCL-Sci  |e MARO  |e CRERAR  |b 63233214  |i 7372428